Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Meeting crawled time : 12:20 save search
YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting
Published: 2024-02-18 (Crawled : 12:20) - prnewswire.com
YS | $0.814 0.38% 0.38% 24K
|
n/a
| Email alert
Add to watchlist
biopharma meeting results
Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2023-11-04 (Crawled : 12:20) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
gda-201 candidate natural cancer cell immunotherapy meeting therapy
FSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 – 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023
Published: 2023-08-15 (Crawled : 12:20) - biospace.com/
HUGE | News | $0.4634 -5.24% -5.52% 280K
|
Process Industries
|
| O: -3.11%
H: 9.29%
C: 2.14%
pharma lucid-ms meeting
Evoke Pharma and EVERSANA Announce Abstract Acceptance at 2023 American Neurogastroenterology and Motility Society (ANMS) Meeting
Published: 2023-08-07 (Crawled : 12:20) - globenewswire.com
EVOK | $0.433 -2.37% -2.42% 9K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -7.84%
pharma eversana meeting
Immix Biopharma Subsidiary Nexcella Announces NXC-201 Multiple Myeloma Clinical Data Abstract Accepted for Presentation at the 20th International Myeloma Society Annual Meeting
Published: 2023-07-25 (Crawled : 12:20) - globenewswire.com
IMMX | $2.15 -6.52% -6.98% 60K
|
|
| O: -1.45%
H: 5.15%
C: 0.49%
nxc-201 presentation international biopharma meeting
Moxian to Hold Annual Meeting of Shareholders on August 25, 2023
Published: 2023-07-18 (Crawled : 12:20) - globenewswire.com
MOXC | $1.01 0.99% 66K
|
Technology Services
|
| O: -0.32%
H: 4.01%
C: 4.01%
meeting
Genesis Unicorn Capital Corp. Announces Filing and Mailing of Definitive Proxy Statement and Special Meeting Date for Proposed Business Combination with Environmental Solutions Group Holdings Limited
Published: 2023-07-07 (Crawled : 12:20) - globenewswire.com
GENQ | $10.47 23.06% 90K
|
n/a
|
| O: -0.37%
H: 0.0%
C: -0.09%
business group solutions meeting
Cellectar Biosciences Highlights Promising Interim Data from Its Ongoing Study of Iopofosine I 131 in Multiple Myeloma in an Oral Presentation at the SNMMI Annual Meeting
Published: 2023-06-28 (Crawled : 12:20) - globenewswire.com
CLRB | $3.045 -2.09% -2.13% 1M
|
Health Technology
|
| O: 3.67%
H: 0.65%
C: -3.02%
presentation ongoing meeting study
ReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the ASMBS 2023 Annual Meeting
Published: 2023-06-28 (Crawled : 12:20) - globenewswire.com
RSLS | $0.1705 3.93% 120K
|
Manufacturing
|
| O: -1.32%
H: 0.81%
C: -5.37%
lifesciences device meeting diabetes
Voting Results from Constellium’s 2023 Annual General Meeting
Published: 2023-06-16 (Crawled : 12:20) - globenewswire.com
CSTM | $19.99 -6.28% 0.0% 2.5M
|
Commercial Services
|
| O: 0.89%
H: 0.12%
C: -1.59%
meeting results
Navitas to Present Next-Gen GaN & SiC Semiconductors at Taiwan Investor Meeting
Published: 2023-06-09 (Crawled : 12:20) - globenewswire.com
NVTS | $4.135 9.1% 8.34% 2.6M
|
Manufacturing
|
| O: 0.64%
H: 0.91%
C: -1.39%
meeting
Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual Meeting
Published: 2023-06-05 (Crawled : 12:20) - globenewswire.com
PRTG | $0.265 9.23% 8.45% 180K
|
Mining, Quarrying, and Oil and ...
|
| O: 2.47%
H: 17.65%
C: 0.8%
lung melanoma biotech cancer cell treatment meeting trial
DIRTT Announces Results of Annual and Special Meeting of Shareholders; Leadership Changes
Published: 2023-05-31 (Crawled : 12:20) - globenewswire.com
DRTT | News | $0.3343 -14.78% 260K
|
Consumer Durables
|
| O: -7.24%
H: 8.09%
C: 3.54%
meeting results
Moderna Announces Phase 2 Data on mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, to be Presented at the 2023 ASCO Annual Meeting
Published: 2023-05-30 (Crawled : 12:20) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 0.18%
H: 2.19%
C: 1.91%
rna-4157 asco meeting
Clever Leaves Reminds Shareholders of its Upcoming Annual Meeting on June 2, 2023
Published: 2023-05-26 (Crawled : 12:20) - globenewswire.com
CLVR | $3.96 2.06% 2.02% 6.1K
|
|
| O: 2.19%
H: 2.33%
C: -0.93%
meeting
Society Pass (Nasdaq: SOPA) Announces 2022 Annual General Meeting of Shareholders on 27 June 2023
Published: 2023-05-24 (Crawled : 12:20) - globenewswire.com
SOPA | $0.1513 8.07% 7.47% 2.7M
|
|
| O: 0.17%
H: 1.32%
C: -4.21%
meeting
Relmada Therapeutics to Present Data at the American Society of Clinical Psychopharmacology 2023 Annual Meeting
Published: 2023-05-24 (Crawled : 12:20) - biospace.com/
RLMD | $3.85 -1.54% -1.56% 110K
|
Health Technology
|
| O: 1.28%
H: 1.26%
C: -2.52%
meeting therapeutics
Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Published: 2023-05-20 (Crawled : 12:20) - globenewswire.com
SNTI | $0.3 -9.04% 51K
|
Health Technology
| Email alert
Add to watchlist
cell meeting therapy
Rocket Pharmaceuticals Presents Positive Data from LV Hematology and AAV Cardiovascular Gene Therapy Programs at the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Published: 2023-05-19 (Crawled : 12:20) - biospace.com/
RCKT 4 | $23.64 -0.13% -0.13% 920K
|
Health Technology
|
| O: 2.35%
H: 1.24%
C: 0.6%
positive cell pharmaceuticals meeting cardiovascular therapy
Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting
Published: 2023-05-18 (Crawled : 12:20) - biospace.com/
PLSE | $6.86 0.0% 130K
|
Health Technology
|
| O: -1.43%
H: 3.5%
C: -4.36%
meeting heart technology
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.